<div id="subtitle">Pfizer's bipolar disorder drug Geodon receives expanded FDA approval</div><div><p>Pfizer Inc. said Friday the Food and Drug Administration approved Geodon as a part of a combination maintenance treatment for bipolar disorder in adults.</p><p>The new approval covers use of Geodon as an adjunct to lithium or valproate.</p><p>The drug is already approved as a treatment for schizophrenia and bipolar disorder.</p><p>Shares of Pfizer rose 20 cents to $18.31 in afternoon trading.</p><img src="http://admatch-syndication.mochila.com/images/ad.gif?aid=63865118&bid=informcom" /></div><div id="copyright"><div>

Copyright 2009  <a href="http://www.ap.org">AP News</a></div></div>